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Our bones are remodelled repeatedly during life. A new and “healthy” bone tissue replaces the old 
one. Accordingly, the bone degrading cells, the osteoclasts, prefer old and fatigued bone. The young 
bone mineral, i.e. calcium apatite, is less crystalline than the mature one. Is it possible that the 
osteoclasts distinguish between relatively old and new bone via its crystallinity? 
 
Methodology/Principal Findings 
Аcid phosphatase is an enzyme largely expressed by the osteoclasts during resorption and therefore 
used as a marker of the cells activity. This study explores whether its enzymatic activity would be 
decreased in the presence of biomimitetically prepared noncrystalline calcium phosphate and 
nanocrystalline bone resembling calcium apatite. The results showed that both biomimetic samples 
decreased significantly the enzyme activity while synthetic calcium phosphate samples did not. 




The in vitro data suggests that the bone-resorbing cells activity could be regulated by the degree of 
crystallinity of the bone mineral. These findings report that changes in the properties of biogenic 
inorganic materials induce specific interactions with biomolecules which in turn should define the 















Bone tissue is remodelled during our entire life. The old and fatigued bone is degraded by 
specialized cells called osteoclasts. Then a new bone is formed by another type of cells, the 
osteoblasts. The degradation itself consists of two parallel processes. The first one is the dissolution 
of the inorganic part of the bone, the mineral calcium apatite. The second one is the degradation of 
the organic, mainly collagenous, matrix by specific proteins and intracellular mechanisms.  
 
Acid phosphatase (AcPho) is an osteoclast-produced enzyme, which is involved in the bone 
resorption process [1, 2]. As a member of the acid phosphatases family this enzyme 
deposphorylates proteins [3]. It is secreted by the human osteoclasts as a tartrate resistant acid 
phosphatase type 5b. In this form it is also involved in the generation of reactive oxygen species 
(ROS) used for the intracellular degradation of collagen fragments [4]. However, the role of this 
largely expressed during resorption enzyme and, therefore used as a marker of the osteoclast 
activity, is still not fully understood [5, 6]. It is known, however, that the most of the bone 
mineralization specific noncollagenous proteins are active only in phosphorylated state [7]. For 
instance, Ek-Rylander et al. showed [8] that once dephosphorylated bone sialoprotein and 
osteopontin could no longer promote the attachment of the osteoclasts to the bone surface.  
 
Bone mineral matures with time and microcracks are generated [9]. There is a growing body of 
evidence that from mineralogical perspective the young and newly formed bone is generally 
disordered [10-16], if not fully amorphous, whereas the old bone is more crystalline, but still in 
nanometer dimensions [17-19]. It has been experimentally shown that the osteoclasts prefer to 
degrade old bone [20, 21]. Do the bone cells recognize the type of bone, i.e. young or old, via its 
crystallinity?  
 
In this study we examined this question assuming that acid phosphatase activity (as a marker of 
bone resorption) should be influenced by the degree of crystallinity of the bone mineral calcium 
apatite. The enzymatic activity, i.e. the enzyme role in the degradation process, should be 
diminished in the presence of young disordered bone mineral. Therefore, we evaluated the change 
of the enzyme activity (EA) in the presence of biomimetically prepared noncrystalline calcium 
phosphate and nanosized apatite. These materials were to some extent similar in terms of 






Preparation of Materials 
Noncrystalline or amorphous calcium phosphate (ACP) and nanocrystalline calcium apatite (CAp) 
were synthesized in simulated body fluid (SBF). SBF is a polyelectrolyte solution mimicking the 
composition of the human plasma [22] at physiological temperature (37 °C). The amorphous 
calcium phosphate was used as well as a precursor for the production of the apatite. The latter was 
achieved via maturation of the ACP in SBF for 24 h. For detailed description see Ref. [23]. 
 
The preparation method used in this study enables the production of bone-like noncrystalline 
calcium phosphate and nanocrystalline apatite. Both products are characterized with large surface 
area and carbonate content similar to the bone ones. The CAp contains very few or no hydroxyl 
groups in its structure, which is an important feature of bone apatite [24]. The samples are bone-
resembling in terms of the concentrations of biogenic ions such as Mg2+, Na+, and K+ present in 
SBF [23].  
 
As standards in this study were used commercially available hydroxyapatite (Ca10(PO4)6(OH)2, HA) 
and dicalcium phosphate dihydrate (CaHPO4.2H2O, DCPD, mineral name: brushite). Both salts 
were purchased from Merck. 
 
Instrumental Analysis 
X-Ray Diffraction analyses were performed using Bruker D8 advanced diffractometer. The data 
obtained was used to calculate the particle size with TOPAS V.3 software and to compare the 
crystallinity of the samples. The phases were identified as well with FTIR by means of Nicolet 
Avatar 360 spectrometer and by the KBr pellet technique. Further analyses (SEM, surface area 
measurments, etc) of the bone-like salts (ACP and CAp) are reported elsewhere [23].   
 
Enzyme Assay 
Acid phosphatase from wheat germ (EC 3.1.3.2.), 0.4 U/mg activity, was purchased from Sigma. 
The substrate of the enzymatic reaction was freshly prepared 25 mM solution of 4-
nitrophenylphosphate (Fluka) in phosphate buffer (pH 5.0). The reaction was stopped with the 
addition of 1M Na2CO3 (Merck). All assays were performed with deionized water and in sterile 
capped plastic tubes at 37°C. 
 
The enzyme was mixed at a concentration of 100 µg/ml with 5 mg calcium phosphate in phosphate 
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buffer (pH 5). The total volume was 5 ml. A series of the above mixtures were incubated for 15 
minutes in water bath with gentle agitation. At 15 min the substrate (25 mM solution of 4-
nitrophenylphosphate) was added and the reaction was stopped after 3, 5, 9, 15, 20, and 30 minutes 
with 200 µL 1M Na2CO3. Finally, the absorbance of the product p-nitrophenolate was read at 405 
nm. The sample/enzyme ratio was 20:1 to reflect as far as possible the natural conditions [3].  
 
We tested additionaly whether the addition of the substrate 4-nitrophenylphosphate at time point 0 
of the interaction between the calcium phosphate samples and the enzyme rather than in the 15th 
minute leads to difference in the final enzyme activity. No statistical difference was found between 
the two enzyme assays (p = 0.369, two-way ANOVA). It should be noted that we chose generally to 
measure the enzyme activity at this pH and buffer rather than the simulated body fluid. The reasons 
being that bone resorption is accomplished at pH 5.0 [1, 2], and about this pH is the optimum for 
the AcPho activity [25, 26]. However, at such an acidic pH some calcium phosphate dissolution 
occurs, but it is reasonable to presume that for the short time periods of the enzyme assay the effect 
is negligible [27].  
 
Additional experiments were performed in SBF (pH = 7.4) as follows. Samples of all the studied 
calcium phosphate materials (1 mg/L in SBF) were added to 4.0 mL enzyme solution. Aliquots (200 
µL) were taken at 0, 5, 10, 20, and 30 min and mixed with 1.0 mL acetate buffer, containing 50 µL 
25 mM 4-nitrophenylphosphate. After 15 min incubation at 37 ºC, 500 µL 1M sodium carbonate 
was added to stop the reaction. The absorbance was read at 405 nm. 
 
Protein Adsorption 
The change of the enzyme concentration with time in the presence of the studied calcium phosphate 
materials was determined directly by spectrophotometry at 562 nm. Standard enzyme solution 
served as a control.  
 
Statistical Analysis 
The statistical analyses were performed by means of SPSS v.13.0. Analysis of variance (ANOVA) 
was used to evaluate the statistical significance of the data and the Tukey Post-hoc test to assess the 
variations of the enzymatic activity over time. Differences at p > 0.05 were considered statistically 







XRD and FTIR Evaluation 
The XRD spectra of the studied materials are shown in Figure 1. The HA and CAp spectra (Fig. 1, a 
and b, respectively) were similar since they have comparable particle size. Using the 002 reflections 
the evaluated crystallite sizes were about 7.73 nm for CAp and about 11.4 nm for HA. Thus both 
materials are nanosized calcium apatites. However, they differ chemically, since the CAp was 
synthesized in simulated body fluid and contained biogenic elements, while HA was relatively pure. 
CAp lacked hydroxyl groups almost entirely [23]. 
 
The ACP (Fig. 1, spectrum c) did not show distinct apatite diffraction peaks, and was thus 
considered as disordered, if not fully amorphous, material. In fact, the exact degree of 
“amorphousness” of the young bone mineral is not known with certainty [28, 29]. Therefore, a 
broad spectrum of non- or low crystalline calcium phosphates could be referred as “bone-like 
amorphous calcium phosphate”. The ACP particle size could not be determined via XRD.  
The DCPD diffractogram (ICDD file 02-0085) manifested a well-crystallized material (Fig. 1, d). 
Its crystallite size is greater than 1 micrometer. 
 
 
Figure 1. XRD sprectra of the samples. HA and CAp (spectra a and b) are characteristic for 
nanocrystalline calcium apatite. HA is more crystalline than CAp, but the difference is not great due 
to comparable crystallite size (see text). ACP (spectrum c) lacks distinct peaks and thus is 
generally deferred as amorphous or noncrystalline material. In contrast the brushite (diffractogram 
d) displays very well crystallized material with crystallite size larger than 1 micrometer.  
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The FTIR examination of the materials confirmed the XRD conclusions (Fig. 2). ACP lacked a 
resolved peak in the υ4 phosphate vibrational region above 530-630 cm-1(Fig. 2, a). This is typical 
for a disordered calcium phosphate phase [11, 12, 23, 30-32]. The spectra of CAp and HA (Fig. 2, b 
and c, respectively) were alike, which reflected their similarity in terms of crystallinity. CAp had 
high carbonate content than HA according to the relative intensity of the peaks at about 1450 and 
873 cm–1. The DCPD spectrum (Fig. 2, d) was characteristic for this calcium phosphate and 




Figure 2. FTIR evaluation of the samples. ACP spectrum (a) manifests noncrystalline calcium 
phosphate, which typically lacks resolved band in the υ4 phosphate vibrational region about 530-
630 cm-1. The higher the crystallinity the greater the splitting in this region. This is well revealed in 
spectra b and c belonging to CAp and HA, respectively. Evidently, according to the FTIR analysis, 
HA is the more crystalline sample, which is consistent with the XRD data. DCPD spectrum (d) 
shows great splitting of the phosphate bands in all regions further confirming its greater 
crystallinity. The peaks about 1491 cm-1, 1430 cm-1 and 873 cm-1 are due to carbonate substitution. 
Such substitution is generally found in bone mineral. The bands about 3400 cm-1 and 1640 cm-1 
originate from bound water and/or hydroxyl ions in the apatite lattice. 
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Both ACP and CAp decrease the enzyme activity, but the ACP effect is stronger  
The effects of ACP and CAp on the AcPho activity are shown in Figure 3. Both materials decreased 
the AcPho activity, with the ACP being the stronger inhibitor. The disordered calcium phosphate 
phase, i. e. the ACP, inhibited the enzyme activity by 9.4% more than CAp in the 30th minute 
(p<0.001). This result is consistent with our initial hypothesis.  
 
It should be noted that in general before the fifth minute the measurements (in all studied samples) 
were not very well duplicated. The enzyme activity difference in the presence of ACP at the 3rd and 
5th minute is not statistically significant (p = 0.19).   
 
 
Figure 3. Changes in acid phosphatase enzyme activity in presence of ACP (White columns) and 
CAp (Grey columns). Error bars represent standard error of the mean [33]. Both samples decrease 
the activity of the enzyme (P < 0.001 for CAp and p = 0.001 for ACP) after the fifth minute, however 
the inhibition effect of ACP is greater (p < 0.001). Asterisk symbol denotes not statistically 
significant difference between samples (see text).  
 
 
HA and DCPD do not decrease the enzyme activity 
Surprisingly, both brushite and HA did not influence the AcPho activity. After 5 minutes incubation 
of the samples the mean values of the enzyme activity remained the same until the end of the assay 
(EA(DCPD) = 0.534; SD = 0.003 and EA(HA) = 0.524; SD = 0.008). This observation suggests that the 
chemical nature of the samples is not responsible for the observed EA decrease. Moreover, we can 
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exclude the crystallite size as a reason for the EA inhibition since CAp and HA have very similar 
crystallite dimensions. 
 
SBF and Ca2+ ions do not decrease the AcPho activity 
To test whether the biogenic ions (Na+, K+, Mg2+, Cl-, CO ) present in ACP and CAp were 
responsible for the observed phenomena, the experiment was performed in SBF. If true, the 
simulated body fluid itself would lower the activity. However, the results obtained in SBF with or 
without samples kept the trend of the ones in phosphate buffer. The SBF pH of 7.4 did not have 
significant influence on the enzyme activity (data not shown).  
 
We hypothesized as well that the enzyme activity was decreased by calcium ions released from the 
samples during the assay. This idea is highly unlikely [25, 34], but reasonable since ACP has both 
the greater solubility and the stronger inhibition effect on the EA compared to CAp. However, we 
found no correlation between the calcium concentrations in both SBF and phosphate buffer and the 
AcPho activity (data not shown). 
  
The enzyme activity decrease is not due to protein adsorption 
We tested whether a protein adsorption process caused the observed trends. The results are shown 
on Table 1. They indicated surprisingly that there was no enzyme adsorption by any of the studied 
materials. Thus, we must rule out the hypothesis that an adsorption is responsible for the inhibition 
of the acid phosphatase enzyme activity in the presence of bone-like minerals. 
 
 
Table 1. Adsorption of acid phosphatase in the presence of the studied samples.  
Absorbance @ 562 nm [mean value ± SD] Substance 
Control 5 min 15 min 30 min 
ACP 1.295 ± 0.001 1.297 ± 0.003 1.295 ± 0.002 1.307 ± 0.003 
CAp 1.218 ± 0.001 1.217 ± 0.000 1.225 ± 0.000 1.227 ± 0.003 
DCPD 1.143 ± 0.003 1.147 ± 0.003 1.144 ± 0.002 1.148 ± 0.002 
HA 1.292 ± 0.002 1.292 ± 0.003 1.295 ± 0.002 1.295 ± 0.001 
The data is reported as a mean value of four replicates with their standard deviations 
(SD). Some time points are omitted from the Table since there is no statistical 





This study illustrates that inorganic materials can interact specifically with an enzyme, changing its 
enzymatic activity. An intriguing hypothesis can be proposed. If the results are confirmed under 
more native conditions, this will show that particular inorganic material-biomolecule interaction can 
command the cell behaviour. Briefly, we speculate that the osteoclasts resorption activity, which is 
greater in the case of the old and more crystalline bone, is somehow regulated via the inhibition of 
the acid phosphatase enzyme. The latter protein is strongly expressed in vivo during resorption and 
therefore is used as a marker of the osteoclastic activity. However the exact role(s) of the enzyme in 
the degradation process is still unknown. 
 
What causes the observed inhibition of the enzyme activity in the presence of bone-like minerals, 
but not in the presence of other calcium phosphates salts? Why does the noncrystalline biomimetic 
precursor show greater inhibition effect than the bone-like nanocrystalline apatite? 
 
As reported here it is highly unlikely that these findings can be ascribed to chemical nature of the 
samples, adsorption, or even crystallinity since CAp and HA have almost the same crystallite 
characteristics. Thus, we believe that some kind of surface phenomenon is driving the observed 
trends. One possibility is that the surface charge of amorphous calcium phosphate is positive [35], 
while the one of calcium apatite is negative. The greater the crystallinity of the latter, the greater its 
negative surface charge [36]. However, to the best of our knowledge, the isoelectric point (pI) of 
wheat germ AcPho is not exactly defined since the enzyme is constituted by several isozymes with 
pI values ranging from about 4.0 to 7.5 [37, 38]. Thus, it is impossible to define the AcPho surface 
charge in phosphate buffer (pH = 5) and to judge with certainty whether the particles electric charge 
is responsible for the observed phenomenon.  
 
There are other difference between the studied materials, which should be taken into consideration, 
such as the following: ACP and CAp have larger surface areas than HA and DCPD (ACP has the 
largest of all); CAp does not contain hydroxyl ions in its crystal lattice in contrast to HA [23]; Some 
transformation, i.e. crystallisation, occurs with the ACP sample during the time of the enzyme 
activity essay [39, 40]; Both ACP and CAp have high carbonate content (5-7 wt%) similar to bone 
mineral. HA is almost carbonate free (Fig. 2, c); DCPD has different type crystal lattice than HA 
and CAp. Hopefully, some of these could help in finding the explanation of the observed 
phenomenon in the future. One should assume as well that the human osteoclats AcPho is tartrate 
resistant and contains two iron ions (II and III) [3]. The wheat germ enzyme used here is not tartrate 
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resistant and does not contain Fe ions as we confirmed by means of atomic adsorption spectroscopy. 
 
In conclusion, this study indicates the possibility that according to its crystallinity the bone mineral 
itself control the osteoclast acid phosphatase activity and hence probably the cell behaviour. In 
compliance we found that both noncrystalline calcium phosphate and nanocrystaline apatite inhibit 
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